Last reviewed · How we verify

NCT06325163

Accuracy of Artificial Intelligence Technology in Detecting Number of Root Canals in Human Mandibular First Molars Obturated and Indicated for Retreatment: Diagnostic Accuracy Experimental Study

Completed NA Last updated 22 March 2024
What this trial tests

NA trial testing CBCT in Missed Canals in 35 participants. Completed in 10 October 2023.

Timeline
25 January 2023
Primary endpoint
2 October 2023
10 October 2023

Quick facts

Lead sponsorMisr International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsequential
Maskingnone
Primary purposediagnostic
Enrollment35
Start date25 January 2023
Primary completion2 October 2023
Estimated completion10 October 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Misr International University

Who can join

Adults 18 to 40, any sex, with Missed Canals. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

evaluate the accuracy of new AI technology for detecting root canals in mandibular first molars retreatment cases in comparison to dentist clinical access cavity and CBCT imaging.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of CBCT

Trials testing the same drug.

Other Misr International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06325163.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing